nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A7—Vincristine—sarcoma	0.0926	0.179	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0926	0.179	CbGbCtD
Zaleplon—CYP3A4—Thiotepa—sarcoma	0.0915	0.177	CbGbCtD
Zaleplon—CYP3A5—Vincristine—sarcoma	0.0694	0.134	CbGbCtD
Zaleplon—CYP3A5—Etoposide—sarcoma	0.0636	0.123	CbGbCtD
Zaleplon—CYP3A4—Mitoxantrone—sarcoma	0.0393	0.076	CbGbCtD
Zaleplon—CYP3A4—Vincristine—sarcoma	0.0271	0.0523	CbGbCtD
Zaleplon—CYP3A4—Etoposide—sarcoma	0.0248	0.0479	CbGbCtD
Zaleplon—CYP3A4—Doxorubicin—sarcoma	0.0169	0.0327	CbGbCtD
Zaleplon—TSPO—hindlimb—sarcoma	0.00349	0.121	CbGeAlD
Zaleplon—TSPO—appendage—sarcoma	0.00299	0.104	CbGeAlD
Zaleplon—AOX1—myometrium—sarcoma	0.00121	0.042	CbGeAlD
Zaleplon—AOX1—seminal vesicle—sarcoma	0.00109	0.038	CbGeAlD
Zaleplon—TSPO—myometrium—sarcoma	0.00103	0.0359	CbGeAlD
Zaleplon—TSPO—embryo—sarcoma	0.000994	0.0345	CbGeAlD
Zaleplon—TSPO—seminal vesicle—sarcoma	0.000934	0.0324	CbGeAlD
Zaleplon—TSPO—hematopoietic system—sarcoma	0.000887	0.0308	CbGeAlD
Zaleplon—TSPO—connective tissue—sarcoma	0.000854	0.0297	CbGeAlD
Zaleplon—CYP3A7—liver—sarcoma	0.000809	0.0281	CbGeAlD
Zaleplon—AOX1—cardiac atrium—sarcoma	0.000789	0.0274	CbGeAlD
Zaleplon—AOX1—uterus—sarcoma	0.000785	0.0272	CbGeAlD
Zaleplon—TSPO—smooth muscle tissue—sarcoma	0.000781	0.0271	CbGeAlD
Zaleplon—GABRB3—connective tissue—sarcoma	0.000776	0.0269	CbGeAlD
Zaleplon—TSPO—skin of body—sarcoma	0.000771	0.0268	CbGeAlD
Zaleplon—CYP3A7-CYP3A51P—liver—sarcoma	0.000688	0.0239	CbGeAlD
Zaleplon—AOX1—tendon—sarcoma	0.000687	0.0239	CbGeAlD
Zaleplon—TSPO—cardiac atrium—sarcoma	0.000674	0.0234	CbGeAlD
Zaleplon—TSPO—uterus—sarcoma	0.00067	0.0233	CbGeAlD
Zaleplon—TSPO—lymphoid tissue—sarcoma	0.000625	0.0217	CbGeAlD
Zaleplon—TSPO—tendon—sarcoma	0.000587	0.0204	CbGeAlD
Zaleplon—GABRB2—testis—sarcoma	0.000575	0.02	CbGeAlD
Zaleplon—AOX1—testis—sarcoma	0.000569	0.0198	CbGeAlD
Zaleplon—TSPO—bone marrow—sarcoma	0.000569	0.0198	CbGeAlD
Zaleplon—CYP3A5—hematopoietic system—sarcoma	0.00055	0.0191	CbGeAlD
Zaleplon—AOX1—liver—sarcoma	0.000538	0.0187	CbGeAlD
Zaleplon—TSPO—testis—sarcoma	0.000486	0.0169	CbGeAlD
Zaleplon—Constipation—Vincristine—sarcoma	0.000465	0.00102	CcSEcCtD
Zaleplon—Pain—Vincristine—sarcoma	0.000465	0.00102	CcSEcCtD
Zaleplon—Osteoarthritis—Doxorubicin—sarcoma	0.000465	0.00102	CcSEcCtD
Zaleplon—Diplopia—Doxorubicin—sarcoma	0.000465	0.00102	CcSEcCtD
Zaleplon—Liver function test abnormal—Epirubicin—sarcoma	0.000463	0.00102	CcSEcCtD
Zaleplon—Dry skin—Epirubicin—sarcoma	0.00046	0.00101	CcSEcCtD
Zaleplon—Decreased appetite—Mitoxantrone—sarcoma	0.00046	0.00101	CcSEcCtD
Zaleplon—TSPO—liver—sarcoma	0.00046	0.016	CbGeAlD
Zaleplon—Chest pain—Etoposide—sarcoma	0.000459	0.00101	CcSEcCtD
Zaleplon—Orthostatic hypotension—Epirubicin—sarcoma	0.000459	0.00101	CcSEcCtD
Zaleplon—Migraine—Doxorubicin—sarcoma	0.000457	0.00101	CcSEcCtD
Zaleplon—Affect lability—Doxorubicin—sarcoma	0.000457	0.00101	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000456	0.00101	CcSEcCtD
Zaleplon—Discomfort—Etoposide—sarcoma	0.000454	0.001	CcSEcCtD
Zaleplon—Breast disorder—Epirubicin—sarcoma	0.000454	0.001	CcSEcCtD
Zaleplon—Pain—Mitoxantrone—sarcoma	0.000453	0.000998	CcSEcCtD
Zaleplon—Constipation—Mitoxantrone—sarcoma	0.000453	0.000998	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000452	0.000997	CcSEcCtD
Zaleplon—Face oedema—Doxorubicin—sarcoma	0.000448	0.000989	CcSEcCtD
Zaleplon—Gastrointestinal pain—Vincristine—sarcoma	0.000444	0.00098	CcSEcCtD
Zaleplon—Gastritis—Epirubicin—sarcoma	0.000444	0.00098	CcSEcCtD
Zaleplon—Confusional state—Etoposide—sarcoma	0.000444	0.000979	CcSEcCtD
Zaleplon—Muscular weakness—Epirubicin—sarcoma	0.000443	0.000976	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000443	0.000976	CcSEcCtD
Zaleplon—GABRB3—testis—sarcoma	0.000441	0.0153	CbGeAlD
Zaleplon—Anaphylactic shock—Etoposide—sarcoma	0.00044	0.000971	CcSEcCtD
Zaleplon—Mood swings—Doxorubicin—sarcoma	0.00044	0.00097	CcSEcCtD
Zaleplon—Asthenia—Thiotepa—sarcoma	0.00044	0.00097	CcSEcCtD
Zaleplon—Ataxia—Doxorubicin—sarcoma	0.000437	0.000963	CcSEcCtD
Zaleplon—Asthenia—Dactinomycin—sarcoma	0.000436	0.000962	CcSEcCtD
Zaleplon—Feeling abnormal—Mitoxantrone—sarcoma	0.000436	0.000962	CcSEcCtD
Zaleplon—Dysphagia—Epirubicin—sarcoma	0.000434	0.000957	CcSEcCtD
Zaleplon—Asthma—Epirubicin—sarcoma	0.000434	0.000957	CcSEcCtD
Zaleplon—Pruritus—Thiotepa—sarcoma	0.000434	0.000956	CcSEcCtD
Zaleplon—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000433	0.000954	CcSEcCtD
Zaleplon—Tachycardia—Etoposide—sarcoma	0.00043	0.000947	CcSEcCtD
Zaleplon—Eosinophilia—Epirubicin—sarcoma	0.00043	0.000947	CcSEcCtD
Zaleplon—Body temperature increased—Vincristine—sarcoma	0.00043	0.000947	CcSEcCtD
Zaleplon—Abdominal pain—Vincristine—sarcoma	0.00043	0.000947	CcSEcCtD
Zaleplon—Liver function test abnormal—Doxorubicin—sarcoma	0.000429	0.000946	CcSEcCtD
Zaleplon—Skin disorder—Etoposide—sarcoma	0.000428	0.000943	CcSEcCtD
Zaleplon—Dry skin—Doxorubicin—sarcoma	0.000426	0.000939	CcSEcCtD
Zaleplon—Hyperhidrosis—Etoposide—sarcoma	0.000426	0.000938	CcSEcCtD
Zaleplon—Orthostatic hypotension—Doxorubicin—sarcoma	0.000424	0.000936	CcSEcCtD
Zaleplon—Angina pectoris—Epirubicin—sarcoma	0.000423	0.000932	CcSEcCtD
Zaleplon—Urticaria—Mitoxantrone—sarcoma	0.00042	0.000927	CcSEcCtD
Zaleplon—Breast disorder—Doxorubicin—sarcoma	0.00042	0.000926	CcSEcCtD
Zaleplon—Anorexia—Etoposide—sarcoma	0.00042	0.000925	CcSEcCtD
Zaleplon—Body temperature increased—Mitoxantrone—sarcoma	0.000418	0.000923	CcSEcCtD
Zaleplon—Abdominal pain—Mitoxantrone—sarcoma	0.000418	0.000923	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000418	0.000923	CcSEcCtD
Zaleplon—GABRB3—liver—sarcoma	0.000417	0.0145	CbGeAlD
Zaleplon—Bronchitis—Epirubicin—sarcoma	0.000417	0.00092	CcSEcCtD
Zaleplon—AOX1—lymph node—sarcoma	0.000413	0.0143	CbGeAlD
Zaleplon—CYP3A4—hematopoietic system—sarcoma	0.000412	0.0143	CbGeAlD
Zaleplon—Hypotension—Etoposide—sarcoma	0.000411	0.000907	CcSEcCtD
Zaleplon—Gastritis—Doxorubicin—sarcoma	0.000411	0.000907	CcSEcCtD
Zaleplon—Muscular weakness—Doxorubicin—sarcoma	0.00041	0.000904	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00041	0.000904	CcSEcCtD
Zaleplon—Dysuria—Epirubicin—sarcoma	0.000406	0.000895	CcSEcCtD
Zaleplon—Dizziness—Thiotepa—sarcoma	0.000405	0.000894	CcSEcCtD
Zaleplon—Asthma—Doxorubicin—sarcoma	0.000401	0.000885	CcSEcCtD
Zaleplon—Dysphagia—Doxorubicin—sarcoma	0.000401	0.000885	CcSEcCtD
Zaleplon—Pollakiuria—Epirubicin—sarcoma	0.000401	0.000884	CcSEcCtD
Zaleplon—Eosinophilia—Doxorubicin—sarcoma	0.000398	0.000877	CcSEcCtD
Zaleplon—Photosensitivity reaction—Epirubicin—sarcoma	0.000396	0.000873	CcSEcCtD
Zaleplon—Paraesthesia—Etoposide—sarcoma	0.000395	0.000872	CcSEcCtD
Zaleplon—Weight increased—Epirubicin—sarcoma	0.000395	0.000871	CcSEcCtD
Zaleplon—Weight decreased—Epirubicin—sarcoma	0.000393	0.000866	CcSEcCtD
Zaleplon—Dyspnoea—Etoposide—sarcoma	0.000392	0.000865	CcSEcCtD
Zaleplon—Hyperglycaemia—Epirubicin—sarcoma	0.000391	0.000863	CcSEcCtD
Zaleplon—Somnolence—Etoposide—sarcoma	0.000391	0.000863	CcSEcCtD
Zaleplon—Angina pectoris—Doxorubicin—sarcoma	0.000391	0.000862	CcSEcCtD
Zaleplon—Asthenia—Vincristine—sarcoma	0.00039	0.00086	CcSEcCtD
Zaleplon—Pneumonia—Epirubicin—sarcoma	0.000389	0.000858	CcSEcCtD
Zaleplon—Rash—Thiotepa—sarcoma	0.000386	0.000852	CcSEcCtD
Zaleplon—Bronchitis—Doxorubicin—sarcoma	0.000386	0.000852	CcSEcCtD
Zaleplon—Dermatitis—Thiotepa—sarcoma	0.000386	0.000851	CcSEcCtD
Zaleplon—Headache—Thiotepa—sarcoma	0.000384	0.000847	CcSEcCtD
Zaleplon—Rash—Dactinomycin—sarcoma	0.000383	0.000846	CcSEcCtD
Zaleplon—Decreased appetite—Etoposide—sarcoma	0.000383	0.000844	CcSEcCtD
Zaleplon—GABRA2—lymph node—sarcoma	0.000381	0.0132	CbGeAlD
Zaleplon—Gastrointestinal disorder—Etoposide—sarcoma	0.00038	0.000838	CcSEcCtD
Zaleplon—Asthenia—Mitoxantrone—sarcoma	0.00038	0.000837	CcSEcCtD
Zaleplon—Neuropathy peripheral—Epirubicin—sarcoma	0.000379	0.000836	CcSEcCtD
Zaleplon—Stomatitis—Epirubicin—sarcoma	0.000377	0.000832	CcSEcCtD
Zaleplon—Pain—Etoposide—sarcoma	0.000376	0.00083	CcSEcCtD
Zaleplon—Constipation—Etoposide—sarcoma	0.000376	0.00083	CcSEcCtD
Zaleplon—Conjunctivitis—Epirubicin—sarcoma	0.000376	0.000829	CcSEcCtD
Zaleplon—Dysuria—Doxorubicin—sarcoma	0.000375	0.000828	CcSEcCtD
Zaleplon—Sweating—Epirubicin—sarcoma	0.000371	0.000818	CcSEcCtD
Zaleplon—Pollakiuria—Doxorubicin—sarcoma	0.000371	0.000818	CcSEcCtD
Zaleplon—Haematuria—Epirubicin—sarcoma	0.000369	0.000814	CcSEcCtD
Zaleplon—Photosensitivity reaction—Doxorubicin—sarcoma	0.000366	0.000808	CcSEcCtD
Zaleplon—Hepatobiliary disease—Epirubicin—sarcoma	0.000366	0.000807	CcSEcCtD
Zaleplon—Weight increased—Doxorubicin—sarcoma	0.000365	0.000806	CcSEcCtD
Zaleplon—Epistaxis—Epirubicin—sarcoma	0.000365	0.000805	CcSEcCtD
Zaleplon—Nausea—Thiotepa—sarcoma	0.000364	0.000803	CcSEcCtD
Zaleplon—Weight decreased—Doxorubicin—sarcoma	0.000363	0.000801	CcSEcCtD
Zaleplon—Feeling abnormal—Etoposide—sarcoma	0.000363	0.0008	CcSEcCtD
Zaleplon—Hyperglycaemia—Doxorubicin—sarcoma	0.000362	0.000799	CcSEcCtD
Zaleplon—Nausea—Dactinomycin—sarcoma	0.000361	0.000797	CcSEcCtD
Zaleplon—Pneumonia—Doxorubicin—sarcoma	0.00036	0.000794	CcSEcCtD
Zaleplon—Gastrointestinal pain—Etoposide—sarcoma	0.00036	0.000794	CcSEcCtD
Zaleplon—Dizziness—Vincristine—sarcoma	0.000359	0.000792	CcSEcCtD
Zaleplon—TSPO—lymph node—sarcoma	0.000352	0.0122	CbGeAlD
Zaleplon—Neuropathy peripheral—Doxorubicin—sarcoma	0.000351	0.000774	CcSEcCtD
Zaleplon—Urticaria—Etoposide—sarcoma	0.00035	0.000771	CcSEcCtD
Zaleplon—Stomatitis—Doxorubicin—sarcoma	0.000349	0.00077	CcSEcCtD
Zaleplon—Abdominal pain—Etoposide—sarcoma	0.000348	0.000767	CcSEcCtD
Zaleplon—Body temperature increased—Etoposide—sarcoma	0.000348	0.000767	CcSEcCtD
Zaleplon—Conjunctivitis—Doxorubicin—sarcoma	0.000348	0.000767	CcSEcCtD
Zaleplon—Hypoaesthesia—Epirubicin—sarcoma	0.000346	0.000762	CcSEcCtD
Zaleplon—Sweating—Doxorubicin—sarcoma	0.000343	0.000757	CcSEcCtD
Zaleplon—Rash—Vincristine—sarcoma	0.000343	0.000756	CcSEcCtD
Zaleplon—Dermatitis—Vincristine—sarcoma	0.000342	0.000755	CcSEcCtD
Zaleplon—Oedema peripheral—Epirubicin—sarcoma	0.000342	0.000755	CcSEcCtD
Zaleplon—Haematuria—Doxorubicin—sarcoma	0.000341	0.000753	CcSEcCtD
Zaleplon—Headache—Vincristine—sarcoma	0.00034	0.000751	CcSEcCtD
Zaleplon—Hepatobiliary disease—Doxorubicin—sarcoma	0.000339	0.000747	CcSEcCtD
Zaleplon—Epistaxis—Doxorubicin—sarcoma	0.000338	0.000745	CcSEcCtD
Zaleplon—Visual impairment—Epirubicin—sarcoma	0.000335	0.000738	CcSEcCtD
Zaleplon—Rash—Mitoxantrone—sarcoma	0.000334	0.000736	CcSEcCtD
Zaleplon—Dermatitis—Mitoxantrone—sarcoma	0.000333	0.000735	CcSEcCtD
Zaleplon—Headache—Mitoxantrone—sarcoma	0.000332	0.000731	CcSEcCtD
Zaleplon—Eye disorder—Epirubicin—sarcoma	0.000325	0.000716	CcSEcCtD
Zaleplon—Tinnitus—Epirubicin—sarcoma	0.000324	0.000714	CcSEcCtD
Zaleplon—Nausea—Vincristine—sarcoma	0.000323	0.000712	CcSEcCtD
Zaleplon—Hypoaesthesia—Doxorubicin—sarcoma	0.00032	0.000705	CcSEcCtD
Zaleplon—Oedema peripheral—Doxorubicin—sarcoma	0.000317	0.000698	CcSEcCtD
Zaleplon—Asthenia—Etoposide—sarcoma	0.000316	0.000697	CcSEcCtD
Zaleplon—Nausea—Mitoxantrone—sarcoma	0.000314	0.000693	CcSEcCtD
Zaleplon—Immune system disorder—Epirubicin—sarcoma	0.000314	0.000692	CcSEcCtD
Zaleplon—Chills—Epirubicin—sarcoma	0.000312	0.000687	CcSEcCtD
Zaleplon—Pruritus—Etoposide—sarcoma	0.000311	0.000687	CcSEcCtD
Zaleplon—Visual impairment—Doxorubicin—sarcoma	0.00031	0.000683	CcSEcCtD
Zaleplon—Alopecia—Epirubicin—sarcoma	0.000307	0.000677	CcSEcCtD
Zaleplon—Mental disorder—Epirubicin—sarcoma	0.000304	0.000671	CcSEcCtD
Zaleplon—Malnutrition—Epirubicin—sarcoma	0.000302	0.000667	CcSEcCtD
Zaleplon—Eye disorder—Doxorubicin—sarcoma	0.0003	0.000662	CcSEcCtD
Zaleplon—Tinnitus—Doxorubicin—sarcoma	0.0003	0.000661	CcSEcCtD
Zaleplon—Flatulence—Epirubicin—sarcoma	0.000298	0.000657	CcSEcCtD
Zaleplon—Tension—Epirubicin—sarcoma	0.000297	0.000654	CcSEcCtD
Zaleplon—Dysgeusia—Epirubicin—sarcoma	0.000296	0.000653	CcSEcCtD
Zaleplon—Nervousness—Epirubicin—sarcoma	0.000294	0.000648	CcSEcCtD
Zaleplon—Back pain—Epirubicin—sarcoma	0.000292	0.000645	CcSEcCtD
Zaleplon—Dizziness—Etoposide—sarcoma	0.000291	0.000642	CcSEcCtD
Zaleplon—Immune system disorder—Doxorubicin—sarcoma	0.00029	0.00064	CcSEcCtD
Zaleplon—Chills—Doxorubicin—sarcoma	0.000288	0.000636	CcSEcCtD
Zaleplon—CYP3A5—liver—sarcoma	0.000285	0.00989	CbGeAlD
Zaleplon—Alopecia—Doxorubicin—sarcoma	0.000284	0.000626	CcSEcCtD
Zaleplon—Mental disorder—Doxorubicin—sarcoma	0.000282	0.000621	CcSEcCtD
Zaleplon—Ill-defined disorder—Epirubicin—sarcoma	0.000281	0.000619	CcSEcCtD
Zaleplon—Malnutrition—Doxorubicin—sarcoma	0.00028	0.000617	CcSEcCtD
Zaleplon—Anaemia—Epirubicin—sarcoma	0.000279	0.000616	CcSEcCtD
Zaleplon—Agitation—Epirubicin—sarcoma	0.000278	0.000613	CcSEcCtD
Zaleplon—Rash—Etoposide—sarcoma	0.000278	0.000612	CcSEcCtD
Zaleplon—Dermatitis—Etoposide—sarcoma	0.000277	0.000612	CcSEcCtD
Zaleplon—Headache—Etoposide—sarcoma	0.000276	0.000608	CcSEcCtD
Zaleplon—Flatulence—Doxorubicin—sarcoma	0.000276	0.000608	CcSEcCtD
Zaleplon—Tension—Doxorubicin—sarcoma	0.000275	0.000605	CcSEcCtD
Zaleplon—Dysgeusia—Doxorubicin—sarcoma	0.000274	0.000604	CcSEcCtD
Zaleplon—Malaise—Epirubicin—sarcoma	0.000273	0.000601	CcSEcCtD
Zaleplon—Nervousness—Doxorubicin—sarcoma	0.000272	0.000599	CcSEcCtD
Zaleplon—Vertigo—Epirubicin—sarcoma	0.000272	0.000599	CcSEcCtD
Zaleplon—Syncope—Epirubicin—sarcoma	0.000271	0.000598	CcSEcCtD
Zaleplon—Back pain—Doxorubicin—sarcoma	0.000271	0.000597	CcSEcCtD
Zaleplon—Palpitations—Epirubicin—sarcoma	0.000267	0.000589	CcSEcCtD
Zaleplon—Loss of consciousness—Epirubicin—sarcoma	0.000266	0.000586	CcSEcCtD
Zaleplon—Nausea—Etoposide—sarcoma	0.000261	0.000577	CcSEcCtD
Zaleplon—Hypertension—Epirubicin—sarcoma	0.000261	0.000576	CcSEcCtD
Zaleplon—Ill-defined disorder—Doxorubicin—sarcoma	0.00026	0.000572	CcSEcCtD
Zaleplon—Anaemia—Doxorubicin—sarcoma	0.000259	0.00057	CcSEcCtD
Zaleplon—Myalgia—Epirubicin—sarcoma	0.000257	0.000568	CcSEcCtD
Zaleplon—Chest pain—Epirubicin—sarcoma	0.000257	0.000568	CcSEcCtD
Zaleplon—Arthralgia—Epirubicin—sarcoma	0.000257	0.000568	CcSEcCtD
Zaleplon—Agitation—Doxorubicin—sarcoma	0.000257	0.000567	CcSEcCtD
Zaleplon—Anxiety—Epirubicin—sarcoma	0.000257	0.000566	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000256	0.000564	CcSEcCtD
Zaleplon—Discomfort—Epirubicin—sarcoma	0.000254	0.000561	CcSEcCtD
Zaleplon—Malaise—Doxorubicin—sarcoma	0.000252	0.000556	CcSEcCtD
Zaleplon—Dry mouth—Epirubicin—sarcoma	0.000252	0.000555	CcSEcCtD
Zaleplon—Vertigo—Doxorubicin—sarcoma	0.000251	0.000554	CcSEcCtD
Zaleplon—Syncope—Doxorubicin—sarcoma	0.000251	0.000553	CcSEcCtD
Zaleplon—Confusional state—Epirubicin—sarcoma	0.000249	0.000549	CcSEcCtD
Zaleplon—Palpitations—Doxorubicin—sarcoma	0.000247	0.000545	CcSEcCtD
Zaleplon—Oedema—Epirubicin—sarcoma	0.000247	0.000544	CcSEcCtD
Zaleplon—Anaphylactic shock—Epirubicin—sarcoma	0.000247	0.000544	CcSEcCtD
Zaleplon—Loss of consciousness—Doxorubicin—sarcoma	0.000246	0.000542	CcSEcCtD
Zaleplon—Shock—Epirubicin—sarcoma	0.000243	0.000535	CcSEcCtD
Zaleplon—Nervous system disorder—Epirubicin—sarcoma	0.000242	0.000534	CcSEcCtD
Zaleplon—Hypertension—Doxorubicin—sarcoma	0.000242	0.000533	CcSEcCtD
Zaleplon—Tachycardia—Epirubicin—sarcoma	0.000241	0.000531	CcSEcCtD
Zaleplon—Skin disorder—Epirubicin—sarcoma	0.00024	0.000529	CcSEcCtD
Zaleplon—Hyperhidrosis—Epirubicin—sarcoma	0.000239	0.000526	CcSEcCtD
Zaleplon—Chest pain—Doxorubicin—sarcoma	0.000238	0.000525	CcSEcCtD
Zaleplon—Arthralgia—Doxorubicin—sarcoma	0.000238	0.000525	CcSEcCtD
Zaleplon—Myalgia—Doxorubicin—sarcoma	0.000238	0.000525	CcSEcCtD
Zaleplon—Anxiety—Doxorubicin—sarcoma	0.000237	0.000523	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000237	0.000522	CcSEcCtD
Zaleplon—Discomfort—Doxorubicin—sarcoma	0.000235	0.000519	CcSEcCtD
Zaleplon—Anorexia—Epirubicin—sarcoma	0.000235	0.000519	CcSEcCtD
Zaleplon—Dry mouth—Doxorubicin—sarcoma	0.000233	0.000514	CcSEcCtD
Zaleplon—Hypotension—Epirubicin—sarcoma	0.000231	0.000508	CcSEcCtD
Zaleplon—Confusional state—Doxorubicin—sarcoma	0.00023	0.000508	CcSEcCtD
Zaleplon—Oedema—Doxorubicin—sarcoma	0.000228	0.000504	CcSEcCtD
Zaleplon—Anaphylactic shock—Doxorubicin—sarcoma	0.000228	0.000504	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000225	0.000496	CcSEcCtD
Zaleplon—Shock—Doxorubicin—sarcoma	0.000225	0.000495	CcSEcCtD
Zaleplon—Nervous system disorder—Doxorubicin—sarcoma	0.000224	0.000494	CcSEcCtD
Zaleplon—Insomnia—Epirubicin—sarcoma	0.000223	0.000492	CcSEcCtD
Zaleplon—Tachycardia—Doxorubicin—sarcoma	0.000223	0.000491	CcSEcCtD
Zaleplon—Skin disorder—Doxorubicin—sarcoma	0.000222	0.000489	CcSEcCtD
Zaleplon—Paraesthesia—Epirubicin—sarcoma	0.000222	0.000489	CcSEcCtD
Zaleplon—Hyperhidrosis—Doxorubicin—sarcoma	0.000221	0.000487	CcSEcCtD
Zaleplon—Dyspnoea—Epirubicin—sarcoma	0.00022	0.000485	CcSEcCtD
Zaleplon—Somnolence—Epirubicin—sarcoma	0.000219	0.000484	CcSEcCtD
Zaleplon—Anorexia—Doxorubicin—sarcoma	0.000218	0.00048	CcSEcCtD
Zaleplon—Dyspepsia—Epirubicin—sarcoma	0.000217	0.000479	CcSEcCtD
Zaleplon—Decreased appetite—Epirubicin—sarcoma	0.000214	0.000473	CcSEcCtD
Zaleplon—CYP3A4—liver—sarcoma	0.000214	0.00742	CbGeAlD
Zaleplon—Hypotension—Doxorubicin—sarcoma	0.000213	0.00047	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Epirubicin—sarcoma	0.000213	0.00047	CcSEcCtD
Zaleplon—Constipation—Epirubicin—sarcoma	0.000211	0.000465	CcSEcCtD
Zaleplon—Pain—Epirubicin—sarcoma	0.000211	0.000465	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000208	0.000459	CcSEcCtD
Zaleplon—Insomnia—Doxorubicin—sarcoma	0.000206	0.000455	CcSEcCtD
Zaleplon—Paraesthesia—Doxorubicin—sarcoma	0.000205	0.000452	CcSEcCtD
Zaleplon—Dyspnoea—Doxorubicin—sarcoma	0.000204	0.000449	CcSEcCtD
Zaleplon—Feeling abnormal—Epirubicin—sarcoma	0.000203	0.000448	CcSEcCtD
Zaleplon—Somnolence—Doxorubicin—sarcoma	0.000203	0.000448	CcSEcCtD
Zaleplon—Gastrointestinal pain—Epirubicin—sarcoma	0.000202	0.000445	CcSEcCtD
Zaleplon—Dyspepsia—Doxorubicin—sarcoma	0.000201	0.000443	CcSEcCtD
Zaleplon—Decreased appetite—Doxorubicin—sarcoma	0.000198	0.000438	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000197	0.000435	CcSEcCtD
Zaleplon—Urticaria—Epirubicin—sarcoma	0.000196	0.000432	CcSEcCtD
Zaleplon—Constipation—Doxorubicin—sarcoma	0.000195	0.000431	CcSEcCtD
Zaleplon—Pain—Doxorubicin—sarcoma	0.000195	0.000431	CcSEcCtD
Zaleplon—Abdominal pain—Epirubicin—sarcoma	0.000195	0.00043	CcSEcCtD
Zaleplon—Body temperature increased—Epirubicin—sarcoma	0.000195	0.00043	CcSEcCtD
Zaleplon—Feeling abnormal—Doxorubicin—sarcoma	0.000188	0.000415	CcSEcCtD
Zaleplon—Gastrointestinal pain—Doxorubicin—sarcoma	0.000187	0.000412	CcSEcCtD
Zaleplon—Urticaria—Doxorubicin—sarcoma	0.000181	0.0004	CcSEcCtD
Zaleplon—Abdominal pain—Doxorubicin—sarcoma	0.00018	0.000398	CcSEcCtD
Zaleplon—Body temperature increased—Doxorubicin—sarcoma	0.00018	0.000398	CcSEcCtD
Zaleplon—Asthenia—Epirubicin—sarcoma	0.000177	0.00039	CcSEcCtD
Zaleplon—Pruritus—Epirubicin—sarcoma	0.000175	0.000385	CcSEcCtD
Zaleplon—Asthenia—Doxorubicin—sarcoma	0.000164	0.000361	CcSEcCtD
Zaleplon—Dizziness—Epirubicin—sarcoma	0.000163	0.00036	CcSEcCtD
Zaleplon—Pruritus—Doxorubicin—sarcoma	0.000162	0.000356	CcSEcCtD
Zaleplon—Rash—Epirubicin—sarcoma	0.000156	0.000343	CcSEcCtD
Zaleplon—Dermatitis—Epirubicin—sarcoma	0.000155	0.000343	CcSEcCtD
Zaleplon—Headache—Epirubicin—sarcoma	0.000155	0.000341	CcSEcCtD
Zaleplon—Dizziness—Doxorubicin—sarcoma	0.000151	0.000333	CcSEcCtD
Zaleplon—Nausea—Epirubicin—sarcoma	0.000147	0.000323	CcSEcCtD
Zaleplon—Rash—Doxorubicin—sarcoma	0.000144	0.000317	CcSEcCtD
Zaleplon—Dermatitis—Doxorubicin—sarcoma	0.000144	0.000317	CcSEcCtD
Zaleplon—Headache—Doxorubicin—sarcoma	0.000143	0.000315	CcSEcCtD
Zaleplon—Nausea—Doxorubicin—sarcoma	0.000136	0.000299	CcSEcCtD
